HomeTARS • NASDAQ
add
Tarsus Pharmaceuticals Inc
Previous close
$81.83
Day range
$80.65 - $82.23
Year range
$38.51 - $83.33
Market cap
3.47B USD
Avg Volume
446.69K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 118.70M | 146.68% |
Operating expense | 108.63M | 87.59% |
Net income | -12.58M | 46.26% |
Net profit margin | -10.60 | 78.22% |
Earnings per share | -0.30 | 50.82% |
EBITDA | -14.07M | 43.45% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 401.84M | 26.78% |
Total assets | 534.56M | 42.06% |
Total liabilities | 199.48M | 43.70% |
Total equity | 335.08M | — |
Shares outstanding | 42.45M | — |
Price to book | 10.37 | — |
Return on assets | -7.06% | — |
Return on capital | -8.83% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -12.58M | 46.26% |
Cash from operations | 18.26M | 311.01% |
Cash from investing | -4.74M | -251.63% |
Cash from financing | 2.56M | 300.94% |
Net change in cash | 16.08M | 429.09% |
Free cash flow | 20.90M | 513.69% |
About
Founded
2016
Headquarters
Website
Employees
323
